Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed

Summary

Novartis reported Q2 sales growth and made progress on pipeline advancement, while maintaining full-year guidance. The company's financial performance and pipeline developments suggest stable business operations.